Columbia Wanger Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q1 | – | Sell |
-416,200
| Closed | -$37.6M | – | 219 |
|
|
2014
Q4 | $37.6M | Sell |
416,200
-437,600
| -51% | -$39.6M | 0.19% | 173 |
|
|
2014
Q3 | $61.6M | Sell |
853,800
-314,000
| -27% | -$22.7M | 0.28% | 125 |
|
|
2014
Q2 | $72.6M | Sell |
1,167,800
-221,200
| -16% | -$13.8M | 0.29% | 124 |
|
|
2014
Q1 | $94.7M | Sell |
1,389,000
-656,000
| -32% | -$44.7M | 0.37% | 88 |
|
|
2013
Q4 | $144M | Sell |
2,045,000
-315,292
| -13% | -$22.2M | 0.55% | 49 |
|
|
2013
Q3 | $170M | Sell |
2,360,292
-339,708
| -13% | -$24.5M | 0.69% | 36 |
|
|
2013
Q2 | $151M | Buy |
+2,700,000
| New | +$151M | 0.66% | 35 |
|